Jackson Creek Investment Advisors LLC Supernus Pharmaceuticals, Inc. Transaction History

Jackson Creek Investment Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 02, 2023	BUY	$29.91 - $38.73 $54,645 - $70,759	1,827 Added 6.24%	31,118 $935,000
Q1 2023 May 02, 2023	SELL	$34.93 - $42.03 $454 - $546	-13 Reduced 0.04%	29,291 $1.06 Million
Q4 2022 Feb 03, 2023	SELL	$31.09 - $37.88 $27,048 - $32,955	-870 Reduced 2.88%	29,304 $1.05 Million
Q3 2022 Nov 09, 2022	BUY	$28.79 - $35.41 $868,709 - $1.07 Million	30,174 New	30,174 $1.02 Million
Q1 2022 May 03, 2022	SELL	$28.51 - $32.9 $973,131 - $1.12 Million	-34,133 Closed	0 $0
Q4 2021 Feb 01, 2022	BUY	$26.37 - $34.22 $900,087 - $1.17 Million	34,133 New	34,133 $995,000
Q1 2021 May 27, 2021	SELL	$24.15 - $31.45 $1.09 Million - $1.42 Million	-45,119 Closed	0 $0
Q4 2020 Feb 03, 2021	BUY	$17.7 - $25.81 $798,606 - $1.16 Million	45,119 New	45,119 $1.14 Million

283

60.6M

27.7K

11.3K

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $2.11B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

Get notified when there are updates to the investment portfolio of Jackson Creek Investment Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Jackson Creek Investment Advisors LLC with notifications on news.